» Articles » PMID: 15592023

A Postoperative Prognostic Nomogram Predicting Recurrence for Patients with Conventional Clear Cell Renal Cell Carcinoma

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2004 Dec 14
PMID 15592023
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Few published studies have simultaneously analyzed multiple prognostic factors to predict recurrence after surgery for conventional clear cell renal cortical carcinomas. We developed and performed external validation of a postoperative nomogram for this purpose. We used a prospectively updated database of more than 1,400 patients treated at a single institution.

Materials And Methods: From January 1989 to August 2002, 833 nephrectomies (partial and radical) for renal cell carcinoma of conventional clear cell histology performed at Memorial Sloan-Kettering Cancer Center were reviewed from the center's kidney database. Patients with von Hippel-Lindau disease or familial syndromes, as well as patients presenting with synchronous bilateral renal masses, or distant metastases or metastatic regional lymph nodes before or at surgery were excluded from study. We modeled clinicopathological data and disease followup for 701 patients with conventional clear cell renal cell carcinoma. Prognostic variables for the nomogram included pathological stage, Fuhrman grade, tumor size, necrosis, vascular invasion and clinical presentation (ie incidental asymptomatic, locally symptomatic or systemically symptomatic).

Results: Disease recurrence was noted in 72 of 701 patients. Those patients without evidence of disease had a median and maximum followup of 32 and 120 months, respectively. The 5-year probability of freedom from recurrence for the patient cohort was 80.9% (95% confidence interval 75.7% to 85.1%). A nomogram was designed based on a Cox proportional hazards regression model. Following external validation predictions by the nomogram appeared accurate and discriminating, and the concordance index was 0.82.

Conclusions: A nomogram has been developed that can be used to predict the 5-year probability of freedom from recurrence for patients with conventional clear cell renal cell carcinoma. This nomogram may be useful for patient counseling, clinical trial design and effective patient followup strategies.

Citing Articles

Microvascular invasion is associated with poor prognosis in renal cell carcinoma: a retrospective cohort study and meta-analysis.

Xu J, Tan Y, Gao S, Lee W, Ye Y, Deng G Front Oncol. 2024; 14:1417630.

PMID: 39464704 PMC: 11502461. DOI: 10.3389/fonc.2024.1417630.


Machine learning analysis for detecting late recurrence and loss to follow-up after renal cell carcinoma surgery.

Sato K, Sazuka T, Arai T, Sato H, Kanesaka M, Ando K BJUI Compass. 2024; 5(10):950-956.

PMID: 39416750 PMC: 11479800. DOI: 10.1002/bco2.425.


Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective study.

Zhu S, Jin Y, Zhang J, Zhou M, Liu B, Liu X BMC Cancer. 2024; 24(1):1274.

PMID: 39402531 PMC: 11476933. DOI: 10.1186/s12885-024-12982-4.


PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer.

Fultang N, Schwab A, McAneny-Droz S, Grego A, Rodgers S, Torres B Front Oncol. 2024; 14:1343004.

PMID: 38371625 PMC: 10869502. DOI: 10.3389/fonc.2024.1343004.


Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.

Choi C, Kang M, Seo S, Suh J, Song C, Chung J J Korean Med Sci. 2024; 39(3):e11.

PMID: 38258358 PMC: 10803202. DOI: 10.3346/jkms.2024.39.e11.